Top View
- Celgene Fact Sheet
- Therapeutic Class Overview Psoriatic Arthritis Agents: Phosphodiesterase 4 Inhibitors
- Apremilast Is a Selective PDE4 Inhibitor with Regulatory Effects on Innate Immunity, Cellular Signalling (2014), 2 P.H
- Assessment Report for Otezla
- Apremilast (Otezla) Reference Number: ERX.SPMN.168 Effective Date: 10/2016 Last Review Date: 12/2016 Revision Log
- Olumiant (Baricitinib) Annual Review Date: 08/20/2020
- Apremilast Microemulsion As Topical Therapy for Local Inflammation: Design, Characterization and Efficacy Evaluation
- Otezla, INN-Apremilast
- 9.Fareesa Fatima, Roshan.S
- PRODUCT MONOGRAPH Protezla® Apremilast Tablets 10 Mg, 20 Mg, and 30 Mg Selective Immunosuppressant Amgen Canada Inc. 6775 Fi
- ATC/DDD Classification
- International Nonproprietary Names for Pharmaceutical Substances (INN)
- Pre - PA Allowance None ______
- 206088Orig1s000
- Auspar Attachment 1: Product Information for Otezla
- Commissioning Pathway for Pbr Excluded Drugs for Psoriasis Adult with Severe Psoriasis – Use Standard Systemic Therapies Including Ciclosporin, Methotrexate and PUVA
- Advice for Individuals Taking Immunosuppressive Treatments for Their Skin Condition We Appreciate This Is a Very Worrying Time F
- Efficacy and Safety of Apremilast in Chronic Cutaneous Sarcoidosis
- Apremilast in Combination with Clobetasol Spray for the Treatment of Plaque Psoriasis
- High Cost Drugs Pathway for Psoriasis in Adults
- Prior Authorization Inflammatory Conditions – Olumiant® (Baricitinib Tablets)
- 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthriti
- OTEZLA Known Hypersensitivity to Apremilast Or Any Excipients in Formulation (4) Safely and Effectively
- Otezla® (Apremilast) Film Coated Tablets
- NICE TA475 Dimethyl Fumarate for Treating Moderate to Severe Plaque Psoriasis
- 206088Orig1s000
- Imaging Assessment of Tumor Response in the Era of Immunotherapy
- Design, Synthesis and Structure-Activity Relationship of Phthalimides Endowed with Dual Antiproliferative and Immunomodulatory A
- Apremilast Uses and Relevance to the Military
- Thalidomide and Its Analogs: a Potential Immunomodulatory Alternative for Treating Liver Diseases and Cirrhosis
- WO 2019/053612 Al 21 March 2019 (21.03.2019) W 1P O PCT
- Apremilast Reduces Behçet Oral Ulcers Short-Term Prednisolone Improves Hand Oa
- Apremilast (Otezla)
- Alizap® Alizap®
- Slide Presentation
- MEDICAL REVIEW(S) Clinical Investigator Financial Disclosure Review Template
- COMPARISON of the WHO ATC CLASSIFICATION & Ephmra/PBIRG ANATOMICAL CLASSIFICATION
- Immune Response to Vaccination in Patients with Psoriasis Treated with Systemic Therapies
- Cimzia® (Certolizumab Pegol) – Oxford Clinical Policy
- XELJANZ® (TOFACITINIB CITRATE) for the TREATMENT of PSORIATIC ARTHRITIS Food and Drug Administration Advisory Committee Meetin
- ALTERATIONS in ATC CLASSIFICATION/ Valid from January 2017 Sorted According to Previous ATC Code
- Apremilast (OTEZLA) National Drug Monograph January 2015 VA Pharmacy Benefits Management Services, Medical Advisory Panel, and VISN Pharmacist Executives
- Certolizumab Pegol (Cimzia) for Chronic Plaque Psoriasis in Adults NIHRIO (HSRIC) ID: 2406 NICE ID: 9112
- Apremilast Application As Treatment of Oral Ulcers in Behçet Syndrome
- Biologics for the Treatment of Adults with Psoriasis
- Detailed Background and Justification for Good Practice Statements and Recommendations for Medication
- Otezla (Apremilast)
- (CIMZIA) in Psoriatic Arthritis Monograph
- Olumiant – ARIZONA
- Immune Modulating Therapies for Rheumatologic, Dermatologic and Gastrointestinal Diseases
- Joint Guidelines for the Management of Interruption of Biologic Therapies for Elective Surgery in Adults and Children with Rheum
- Otezla® (Apremilast) Tablets Annual Review Date: 08/20/2020
- Celgene Proprietary Information
- Descriptive Comparisons of the Effect of Apremilast and Methotrexate Monotherapy in Oligoarticular Psoriatic Arthritis
- 761032Orig1s000
- Ocular Side Effects of Antirheumatic Medications: a Qualitative Review
- Dimethyl Fumarate for Treating Moderate to Severe Plaque Psoriasis
- Otezla, INN-Apremilast